Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04839809 · ClinicalTrials.gov registry record · Phase 1

A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants

A Phase 1 study of Healthy Volunteers, sponsored by Celgene.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT04839809 is a Phase 1 study of Healthy Volunteers that has completed, run by Celgene. The registered enrollment target is 40 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04839809, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Celgene.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a Phase 1 study that will be conducted in 2 parts. Participants may participate in 1 part only. * Part 1 will be a randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and PK of CC-92480-02 (Formulation A) administered orally under fasted conditions in healthy adult participants. * Part 2 will be a randomized, open-label, 2 × 4 crossover study (Periods 1, 2, 3, and 4) to evaluate the relative bioavailability (RBA) of Formulation A versus Formulation B under fasted conditions and explore safety, tolerability, and PK effects of food on Formulation A and Formulation B in healthy adult participants.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG CC-92480

Study Locations (1)

Texas

  • PPD Phase 1 Clinic - Austin

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-01-19
Est. Completion 2021-10-08
Phase Phase 1

Sponsor

Celgene

308 total trials

What the Registry Record Tells You About NCT04839809

The ClinicalTrials.gov registry entry for NCT04839809 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (92% lower). The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04839809 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04839809 about?

NCT04839809 is a clinical study titled "A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants". This is a Phase 1 study that will be conducted in 2 parts. Participants may participate in 1 part only. * Part 1 will be a randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and PK of CC-92480-02 (Formulation A) administered orally under ...

What is the current status of trial NCT04839809?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2021-01-19. Estimated completion is 2021-10-08.

What conditions does trial NCT04839809 study?

This clinical trial studies the following conditions: Healthy Volunteers.

What interventions are being tested in trial NCT04839809?

The interventions under investigation include: Placebo (OTHER), CC-92480 (DRUG).

Who is sponsoring clinical trial NCT04839809?

This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04839809 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.